Delivery agents which can carry the {Ru(NO)} e chromophore (" caged (5) with the {Ru(NO)} e moiety bound to (2-pyridylmethyl)iminodiacetate (pida) is also characterized as a potential "caged NO" carrier. Structural information concerning the placement of the pyridyl donor groups relative to the {Ru(NO)} e unit has been obtained from H and C NMR and infrared methods, noting that a pyridyl donor trans to NO causes "trans strengthening" of this ligand for [Ru(NO)Cl(pida)], whereas placement of pyridyl groups cis to NO causes a weakening of the N-O bond and a lower NO stretching frequency in the dpa-based complexes.
Introduction
The complex [RuCla(NO)(HO)] (1) has been studied by Bettache, Carter et al. as a source of "caged NO ", a reagent suited to vasodilation and photodynamic therapy [1, 2] . Other photoreleasing systems for NO dissociation have been reviewed [3, 4] . The quantum yield for photolysis of (1) is low (q 0.012] [1] , requiring the development of other ligand donors that can enhance the photo-dissociation chemistry in order to have a viable agent for photodynamic therapy. Additionally, the biodistribution of (1) has not been studied. Information on what physiologically accessible donors bind to the {Ru(NO)} 2 In another current report from our research group [8] , we have described the coordination of the {Ru(NO)} e unit to the peptides (gly-gly-gly-2H) and (gly-gly-his-2H) wherein the peptide adopts a planar coordination with an axial {Ru(NO)} group. Attachment is via the terminal amino donor, two peptido ionized N donors and CI for (gly-gly-gly-2H) or the imidazole donor for (gly-gly-his-2H) [8] . The behavior of the {Ru(NO)} a+ unit toward peptide coordiation is the same as the well-characterized square-planar analogues of Pd , Pt and Ni , except that the {Ru(NO)} + complexes have the axial NO and CI or HO donors, whereas the Ni , Pd , Pt family are strictly square-planar.
The present paper describes stable complexes that can be obtained using pyridyl-based donors for the {Ru(NO)} e core. Godwin and Meyer have prepared a his bipyridine complex,
[Ru(NO)Cl(bpy)]/, which by virtue of steric constraints from the two bpy ligands cannot retain the four pyridyl donors in the plane cis to NO [9] . A pseudo-square planar arrangement of ligands has an appea-I for the development of carrier complexes of NO that might associate with DNA by intercalation as a means of bringing "caged NO" into the environment of DNA. Photolysis of such bound "caged NO" species could then be used to induce local DNA cleavage. Our efforts in this regard have involved the use of the dipyridylamine (dpaH)ligand, which due to the central nitrogen linkage, affords a flexible donor that avoids the steric problems associated with two bipyridines. Indeed, it is reported herein that and 2 complexes with dpaH are obtained with ligands cis to NO+. An extension of the simple dipyridylamine donor in which two dipyridylamine moieties are linked by an adipyl chain forming the recently prepared ligand tpada [10] , has been carried out to incorporate two RuCI3(NO) headgroups that are bound by tpada. This arrangement affords a "caged NO" binuclear complex that in principal can span the major groove of DNA, form local coordination adducts by nucleobase displacement of CI, and can stand ready for the photo-release of NO.
Lastly, the present paper describes the coordination of the pyridyl-aminocarboxylate hybrid ligand (2-pyridylmethyl)iminodiacetate, (pida). NMR evidence indicates a major product [Ru(NO)Cl(pida)] with the pyridyl donor trans to NO+. Such modifications in which the donor properties of the group trans to NO + has promise as a route to enhancement of the photo-lability of the NO chromophore. The {Ru(NO)Cl(pida)] complex may be one of a series of trans-modified, "caged NO" complexes of use to photodynamic therapy.
Materials and Methods
Reagents: [RuCI3(NO)(H20)2 was prepared by the method of Fletcher et al. [11] from RuCI3(H20)3 (Aldrich). 2,2'-dipyridylamine was also used as supplied by Aldrich. (2-pyridylmethyl)iminodiacetic acid (Hpida) synthesized for a former study of the [Fe(NO)(pida)] [12] and used from that supply. N,N,N'N'-tetrakis(2-pyridyl)adipamide (tpada)was synthesized as described in a recent publication [10] . All .4 mol of (1) and 0.3454 g of dpaH (2.02x10 mol) in 35 mL of N-purged water in an N-purged round-bottom flask.
The sample cycle included heating for 2h, removal of a trace of unreacted dpaH by filtration, and concentration of the filtrate at 45C under reduced pressure, followed by drying in the desiccator under vacuum. NMR and IR methods described in the main text establish that the products have high puity, and are absent of unreacted (1) Upon coordination in the [Ru(NO)Cl(dpaH)] product (2) , all four protons are differentiated and shifted relative to the free ligand. The H-6,6' pair moves upfield to 8.18 ppm (singlet) H-4,4' moves upfield to 7 .76 ppm (triplet) while H-3,3' moves downfield to 7 .27 ppm (doublet) and H-5,5' shifts upfield to 7 .03 ppm as an unresolved singlet. The presence of four resonances indicates the non-lability of the coordinated dpaH in contrast to the observations of lability for coordinated imidazole donors [7] . Also, there is only one set of ligand resonances which affirm that the pyridyl donors of dpaH must be placed symmetrically, and hence, cis to NO+, in the [Ru(NO)Cl(dpaH)]
complex. There was no detectable change in the H NMR spectrum with time for over several days, which rules out a facile isomerization in the coordination mode of dpaH in the complex. Therefore the CI ligands occupy the fac positions in the 1:1 dpaH complex, and the dpaH ligand does not readily dissociate.
The presence of the nitrosyl group is confirmed by the FT-IR spectrum, showing o at 850 cm. The significance of this value in confirming a cis-coordinated dpaH ligand will be discussed later.
Developing Carrier Complexes for "Caged NO RuCI3(NO) (H20) This same -conjugation around the amide carbonyl establishes planarity of the carbonyl unit together with the pyridyl ring planes. As a consequence, the two pyridyl rings of tpada are not equivalent upon coordination, whereas the simple dpaH ligand without extended =-conjugation to a carbonyl at the central amine retains an equivalency of the coordinated pyridyl rings on a dpaH ligand as discussed for the [RuCl3(NO)(dpaH)] complex in a prior section of this paper. The C NMR spectra for free tpada and coordinated tpada of the 2 RuCI(NO) tpada complex exhibit the anticipated changes upon coordination, retaining equivalency for positions, even those differentiated by H NMR methods. A spectrum of the 2 complex and the free ligand could not be directly compared. The solubility of free tpada is very low. In order to obtain a sufficiently high concentration that would allow for C data collection, we had to protonate the tpada as H2tpada 2/. In this species the protons are not equivalently shared by the pyridyl N donors, causing inequivalency of all but the C-2,2' carbons. Upon coordination, the equal donation of each N-donor of the bidentate headgroup of tpada toward RuCI(NO) restores the equivalency of the pairwise assignments for the two pyridyl rings. Thus, the H-6,6' protons are more sensitive to differences within the whole complex, stemming from the electronic withdrawing effect and the nearness to the =-conjugation of the amide system than are the pyridyl ring carbons whose energies are dominated by their position within the pyridyi =-cloud rather than peripheral electron densities. The location of the chemical shifts for the ring carbons in the {[RuCl(NO)]2(tpada)} complex are in general upfield by ca. ppm of those of the protonated H2tpada 2+ species.
The infrared spectra of the tpada ligand and its 2:1 complex reveal added features concerning coordination. The nitrosyl stretching frequency is at 1872 cm in {[RuCl(NO)]2(tpada)} compared to 1850 cm in [RuCla(NO)(dpaH)], indicative of the fact that the withdrawing amido functionality of tpada allows for weakened back-donation of the Ru center to coordinated NO+. The free tpada with back-donation from Ru into the pyridyl ring-amido assembly has weakened carbonyl bonds as exhibited by amide stretches at 1655 and 1604 cm in the complex compared to the stronger carbonyl bonds with strettches at 1679 and 1585 cm in the starting tpada ligand.
[Ru(NO)Cl(pida)] Complex (5) The H NMR spectrum of the free ligand pida 2 and its complexes derived from (1) are shown in figure 1A and 1B, repectively. The ligand resonances are defined on the figure. The CH2's of the glycinato arms appear as a singlet, being freely rotating groups in D20 solution. Ring protons for H-6 is an anticipated doublet at 8.60 ppm, H-4 is a multiplet at 7.91 ppm and overlapped H-3 and H-5 protons resonating from 7.46 to 7.61ppm.There are several isomers in the aboundance of 64%, 36% and ca. 1% formed when pida 2" coordinates to (1) . These are identified as isomers A, B and C in the figure.
Developing Carrier Complexes for "Caged NO RuCI3(NO)(H20) (1) , shows that coordination produces a weakening of the NO stretching frequency, rather than the "trans strengthening" when a stronger donor than CI is trans to NO [17] [18] [19] [20] [21] [22] . This confirms the "in-plane" coordination of dpaH, the fac placement of the three CI donors, and the NMR equivalency of the two pyridyl donors.
When the second dpaH ligand is added to (2) (4) is still in the cis-to-NO arrangement as in the simple dpaH complex (2) . The present study has shown that it is possible to prepare a binuclear tethered "caged NO reagent that is structurally capable of spanning the major groove of DNA and afford covalent bond formation by displacement of a CI donor at the Ru center. Solubility difficulties with the binuclear complex (4) cause this complex, itself, to have limited potential use. It is desirable to prepare {Ru(NO)}6-chelated and tethered complexes wherein the chelating site is a -donor rather than the =-acceptor competitor ligand as in tpada. However, the binuclear complex (4) is important as a working model for the design of better antitumor metallodrugs that carry forth the present theme. The better :-donating peptido complex of {Ru(NO)} e derived from (gly-gly-gly-2H) [8] hold high promise in this regard, combining bio-compatibility of the ligand with ones that can be incorporated with more soluble spacer ligand components via rather common synthetic strategies.
The [Ru(NO)Cl(pida)] complex (5) occurs as several isomers. The major isomer (64%) has the pyridyl donor in the position trans to NO+, causing a trans strengthening of the nitrosyl stretch at a calculated value of 1898 cm. An alternate placement of the pyridyl donor at an in-plane position cis to NO occurs 36 % of the time. In this .arrangement, strain and the less good trade of an axial carboxylate for CI than a pyridyl donor for CI prompts a pendant carboxylate instead of the full quaternary donation available from pida that is displayed in the major isomer. In a prior study with the more simple N-methyliminodiacetate ligand (mida) that lacks the pyridyl donor of pida , we observed that one glycinato donor of the two available in mida achieves in-plane coordination to RuCI(NO) and one coordinates axially with the amine donor cis to NO [7] . The [6 8] and in the present manuscript are of value in the design of peptide-transportable antitumor agents. The advantage for those derived from (1) resides in their control against redox side reactions during the transport phase and the possibility of "turning them on" by selective photolysis, once the species is absorbed by the intended tumor.
